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Abstract: Cadmium (Cd) is a widespread environmental pollutant and carcinogen. Although the
exact mechanisms of Cd-induced carcinogenesis remain unclear, previous acute/chronic Cd exposure
studies have shown that Cd exerts its cytotoxic and carcinogenic effects through multiple mechanisms,
including interference with the DNA repair system. However, the effects of post-chronic Cd exposure
remain unknown. Here, we establish a unique post-chronic Cd-exposed human lung cell model
(the “CR0” cells) and investigate the effects of post-chronic Cd exposure on the DNA repair system.
We found that the CR0 cells retained Cd-resistant property even though it was grown in Cd-free
culture medium for over a year. The CR0 cells had lasting DNA damage due to reduced DNA
repair capacity and an aberrant DNA repair gene expression profile. A total of 12 DNA repair genes
associated with post-chronic Cd exposure were identified, and they could be potential biomarkers
for identifying post-chronic Cd exposure. Clinical database analysis suggests that some of the DNA
repair genes play a role in lung cancer patients with different smoking histories. Generally, CR0 cells
were more sensitive to chemotherapeutic (cisplatin, gemcitabine, and vinorelbine tartrate) and DNA
damaging (H2O2) agents, which may represent a double-edged sword for cancer prevention and
treatment. Overall, we demonstrated for the first time that the effects of post-chronic Cd exposure on
human lung cells are long-lasting and different from that of acute and chronic exposures. Findings
from our study unveiled a new perspective on Cd-induced carcinogenesis—the post-chronic exposure
of Cd. This study encourages the field of post-exposure research which is crucial but has long
been ignored.
Keywords: cadmium; post-chronic exposure; DNA damage and repair; BEAS-2B; human lung cells;
cell transformation; carcinogenesis; drug sensitivity
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1. Introduction
Cadmium (Cd), a toxic heavy metal, is a widespread environmental pollutant. Humans are
commonly exposed to Cd through the consumption of contaminated food/drinking water, occupational
inhalation, polluted air, and cigarette smoking. Cd is associated with many human diseases and has
adverse health effects even at low concentrations [1]. It is also a well-known carcinogen where it shows
a particularly strong correlation with lung cancer, one of the most common and deadliest cancers
worldwide [2,3]. Although the exact mechanisms of Cd carcinogenesis remain elusive, researchers
have unveiled that Cd is likely to exert its deleterious effects on cells through multiple mechanisms,
including induction of oxidative stress and inflammation, inhibition of apoptosis, aberration of gene
expression, alteration of DNA methylation, and interference with DNA repair system [4,5].
Cd has the ability to alter the expression of various DNA repair genes, and it is known to be able
to impair DNA repair system via down-regulation of DNA repair genes expression [6,7], suppression
of transcription factor activity [8], and disruption of protein’s function by binding to its zinc finger
motif [4,9]. Interestingly, so far, evidence of Cd interference is overwhelmingly available only for the
repair pathways of single-stranded DNA (ssDNA) damage (e.g., base excision repair (BER), nucleotide
excision repair (NER), and mismatch repair (MMR)), but very limited for double-stranded DNA
(dsDNA) damage such as homologous recombinational repair (HRR) and non-homologous end-joining
(NHEJ). In order to better understand the mechanisms of Cd carcinogenesis, one must look at the
impacts of Cd on the overall DNA repair systems instead of a single DNA repair enzyme. Also, almost
all previous studies on Cd-induced toxicity and carcinogenicity focused only on examining the effects
of either acute [10–12] or chronic [13–15] Cd exposure but have neglected the potential implications of
post-chronic Cd exposure on human health.
The term “chronic exposure” is defined as continuous exposure to a particular compound over
an extended period of time, whereas “post-chronic exposure” is referred to as the state after chronic
exposure, when it is no longer exposed to the particular compound. In the era where exposure to
Cd is of a growing environmental health concern, systematic research on post-chronic Cd exposure
can be extremely important since post-chronic Cd exposure is not only especially relevant to people
like ex-smokers and retired workers in high-risk occupations, but also to people from the general
population who live in Cd-polluted environments [16,17]. Unfortunately, research on post-chronic
exposure of Cd (and other toxic compounds) has so far remained largely unexplored, and this may be
in part due to the lack of such experimental models.
Recent studies have revealed the epigenotoxicity of Cd and thus indicated that Cd toxicity
might be heritable and able to last for generations [18–20]. These findings reinforce the need for
research on post-chronic Cd exposure. In the current study, we established a unique post-chronic
Cd-exposed human bronchial epithelium BEAS-2B cell model (the “CR0” cells) and used this cell
model to study the possible long-term carcinogenic effects of post-chronic Cd exposure on human lung
cells. We specifically focused on the aspects of DNA damage and repair by measuring the DNA repair
capacity and systematically assessing the transcriptomic profile of DNA repair genes in the CR0 cells.
Furthermore, the clinical relevance of our findings in relation to lung cancer and cigarette smoking
was evaluated. Lastly, we tested the chemotherapeutic drug susceptibility of CR0 cells in order to lay
a foundation for future direction on chemo-intervention against Cd-induced lung cancer. Overall,
our study unveiled a new perspective on Cd-induced carcinogenicity—the post-chronic exposure
of Cd.
2. Materials and Methods
2.1. Establishment of Chronic and Post-Chronic Cd-Exposed Human Bronchial Epithelial BEAS-2B Cell Models
The BEAS-2B cell line was purchased from the American Type Culture Collection (ATCC)
(Rockville, MD, USA). Short Tandem Repeat (STR) profiling was performed for cell line authentication
by Guangzhou Cellcook Biotech Co., Ltd. (Guangzhou, China; the STR report is available upon
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request). BEAS-2B cells were isolated from normal human bronchial epithelium obtained from autopsy
of a non-cancerous individual. Cells were routinely grown in LHC-9 medium (Gibco, New York, NY,
USA) at 37 ◦C in an atmosphere of 5% CO2/95% air as recommended by the ATCC. LHC-9 is a defined,
serum-free medium, which is prepared by mixing LHC basal medium with growth factors, cytokines,
and supplements as described previously [21].
For the establishment of a chronic Cd-exposed cell line, BEAS-2B cells were stepwise-adapted
to environmentally-relevant concentrations of CdCl2 in LHC-9 medium with concentrations ranging
from 1 to 20 µM after approximately 20 passages, and subsequently cultured in the presence of 20 µM
CdCl2 for at least 3 months as described previously [19]. Sham-exposed BEAS-2B cells were obtained
as passage-matched control cells (the “PM” cells). The resulting Cd-resistant BEAS-2B cells, along with
the PM control cells, were then continuously cultured in Cd-free LHC-9 medium for more than a year
to obtain the post-chronic Cd-resistant BEAS-2B cell line (the “CR0” cells).
2.2. Determination of Cell Proliferation and Cell Viability
CR0 and PM cells were seeded in 96-well plates at 2000–2500 cells per well in LHC-9 medium
and incubated for at least 8 h. The medium was then changed, and the cells were treated
with various concentrations of cisplatin (Hansoh Pharmaceutical, Jiangsu, China), gemcitabine
(Selleck, Shanghai, China), vinorelbine tartrate (Selleck, Shanghai, China), or H2O2 (Sinopharm
Chemical Reagent Co., Shanghai, China). Cells were incubated for a designated period of
time, and at the end of the experiments, cell proliferation or cell viability was measured by
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS)
assay according to manufacturer’s protocol (Promega, Madison, WI, USA).
2.3. Detection of DNA Damage and DNA Repair Capacity
DNA damages and DNA repair capacity were determined by single cell gel electrophoresis
(the “comet assay”). An alkaline comet assay was performed according to Olive and Banáth, with minor
modifications and adjustments on the glass slides and agarose concentrations for better agarose
adhesion [22]. Images of at least 50 non-overlapping cells per sample were captured using a fluorescence
microscope (Axiovert 40 CFL, ZEISS, Shanghai, China) attached with a digital camera (MicroPublisher
5.0 RTV, Teledyne QImaging, Surrey, British Columbia, Canada) and viewed by the accompanying
software QCapture (v2.9.13, Quantitative Imaging Corp.). Experiments were performed at least three
times for each sample. Individual images were analyzed using the Comet Assay Software Project
software (v1.2.3b2, CASPLab), and the means of the % tail DNA and tail extent moment from three
separate experiments were calculated as measures of DNA damage. The tail extent moment is defined
as “% tail DNA × comet tail length ÷ 100”.
2.4. Determination of Colony Formation Ability
Colony (focus) formation assay was performed to assess the cells’ ability to form colonies as
described in Alvarez et al. with minor modifications [23]. Briefly, cells were seeded in 6-well plates
at 500 cells per well in LHC-9 medium with 20 µM CdCl2 and cultured for a total of seven days.
Cell foci were stained with crystal violet and images were captured using a digital scanner (V370 Photo,
EPSON, Long Beach, CA, USA). Stained foci were solubilized and extracted using 10% acetic acid and
absorbance was measured at 595 nm.
2.5. Detection of Histone H2AFX and γH2AFX Expression
Acid extraction of histones from PM and CR0 cells was performed as described previously [24].
For the detection of H2AFX and γH2AFX expression, 1 µg of histone was separated using 15%
SDS-PAGE and transferred to polyvinylidene difluoride membranes (Merck-Millipore, Darmstadt,
Germany). The membrane was blocked with 5% (w/v) non-fat milk in tris-buffered saline containing
0.05% Tween-20 for 2 h and incubated with H2AFX (1:1000, A11361, ABClonal), γH2AFX (1:1000,
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AP0099, ABClonal), or H3 (1:2000, 4499, CST) antibody at 4 ◦C overnight, followed by anti-rabbit
secondary antibody (1:5000, sc-2004, Santa Cruz), and detected by chemiluminescence (Tanon5200,
Tanon Science & Technology Co., Ltd, Shanghai, China).
2.6. Assessment of Global DNA Repair-Related Gene Expression Profile
The relative DNA repair-related gene expression of CR0 over PM control cells was analyzed using
real-time quantitative polymerase chain reaction (RT-qPCR) on an ABI7500 Real-Time PCR System
(Applied Biosystems, Foster City, CA, USA), and calculated using the comparative CT method (2-∆∆CT
method) [25]. Total RNA was extracted with QIAzol® Lysis Reagent followed by RNeasy Mini Kit
(Qiagen-SABiosciences, Germantown, MD, USA) and reverse-transcribed to cDNA by RT2 First Strand
Kit (Qiagen-SABiosciences, Germantown, MD, USA) according to the manufacturer’s instructions.
For RT-qPCR, cDNA template derived from 10 ng of total RNA was amplified by the appropriate
primer set in a reaction containing RT2 SYBR® Green ROX qPCR Mastermix (Qiagen-SABiosciences,
Germantown, MD, USA).
A total of 117 DNA repair-related genes involved in 16 different DNA repair pathways were
examined in this study (summarized in Table 1). Among them, 78 genes were evaluated using RT2
Profiler™ PCR Arrays for Human DNA Repair (Qiagen-SABiosciences, Germantown, MD, USA)
while 39 genes were evaluated based on primer sequences obtained from RTPrimerDB database
(www.rtprimerdb.org) [26] or designed using Primer-BLAST (Primer3 and NCBI, Bethesda, MD,
USA). Here, we used a novel “scoring system” involving the use of multiple reference/housekeeping
genes to provide us a less biased method to analyze gene expression data. These reference genes
are β-actin (ACTB), β-2-microglobulin (B2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
hypoxanthine-guanine phosphoribosyltransferase (HPRT1), 60S acidic ribosomal protein P0 (PRLP0),
and “5HKGs” (5-housekeeping genes; the “expression value” of 5HKGs is created based on the average
expression levels of the above five reference genes. The specificity and PCR amplification efficiency of
the designed primers were determined by melt curve analysis and a standard curve plot, respectively.
All primers used had a single defined melt curve peak and an efficiency of 90%–110%. Information for
primers used in this study is listed in Table S1.
Table 1. DNA repair genes and their associated DNA repair-related pathways investigated in this study.
Acronym DNA Repair Pathways No. of Genes 1 Gene Name (UniProtKB accession ID)
Major DNA Repair Pathways
BER Base excision repair 38
APEX1 (P27695); CCNO (P22674); ERCC1 (P07992); ERCC4 (Q92889);
ERCC5 (P28715); ERCC6 (Q03468); FEN1 (P39748); GADD45A
(P24522); HUS1 (O60921); LIG1 (P18858); LIG3 (P49916); MBD4
(O95243); MPG (P29372); MUTYH (Q9UIF7); NEIL1 (Q96FI4); NEIL2
(Q969S2); NEIL3 (Q8TAT5); NTHL1 (P78549); OGG1 (O15527); PARP1
(P09874); PARP2 (Q9UGN5); PARP3 (Q9Y6F1); PCNA (P12004);
POLB (P06746); POLD3 (Q15054); RAD23A (P54725); RAD23B
(P54727); RAD52 (P43351); RPA1 (P27694); RPA2 (P15927); RPA3
(P35244); SIRT1 (Q96EB6); SMUG1 (Q53HV7); TDG (Q13569); TP53
(P04637); UNG (P13051); WRN (Q14191); XRCC1 (P18887)
NER Nucleotide excision repair 37
ATR (Q13535); ATXN3 (P54252); CCNH (P51946); CDK7 (P50613);
CETN2 (P41208); DDB1 (Q16531); DDB2 (Q92466); ERCC1 (P07992);
ERCC2 (P18074); ERCC3 (P19447); ERCC4 (Q92889); ERCC5 (P28715);
ERCC6 (Q03468); ERCC8 (Q13216); GADD45A (P24522); GTF2H1
(P32780); GTF2H2 (Q13888); GTF2H3 (Q13889); GTF2H4 (Q92759);
LIG1 (P18858); LIG3 (P49916); MMS19 (Q96T76); NTHL1 (P78549);
OGG1 (O15527); PCNA (P12004); POLD3 (Q15054); RAD23A
(P54725); RAD23B (P54727); RFC1 (P35251); RPA1 (P27694); RPA2
(P15927); RPA3 (P35244); SIRT1 (Q96EB6); TP53 (P04637); XAB2
(Q9HCS7); XPA (P23025); XRCC1 (P18887)
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Table 1. Cont.
Acronym DNA Repair Pathways No. of Genes 1 Gene Name (UniProtKB accession ID)
MMR Mismatch repair 19
ABL1 (P00519); EXO1 (Q9UQ84); MLH1 (P40692); MLH3 (Q9UHC1);
MSH2 (P43246); MSH3 (P20585); MSH4 (O15457); MSH5 (O43196);
MSH6 (P52701); PCNA (P12004); PMS1 (P54277); PMS2 (P54278);
POLD3 (Q15054); RFC1 (P35251); RPA1 (P27694); RPA2 (P15927);
RPA3 (P35244); TDG (Q13569); TREX1 (Q9NSU2)
HRR Homologous recombinationalrepair 49
ATM (Q13315); ATR (Q13535); BLM (P54132); BRCA1 (P38398);
BRCA2 (P51587); BRIP1 (Q9BX63); CHEK1 (O14757); DMC1 (Q14565);
ERCC1 (P07992); ERCC4 (Q92889); ERCC6 (Q03468); FANCA
(O15360); FANCB (Q8NB91); FANCF (Q9NPI8); FANCG (O15287);
FEN1 (P39748); GADD45A (P24522); H2AFX (P16104); HUS1
(O60921); LIG3 (P49916); MDC1 (Q14676); MRE11 (P49959); MSH2
(P43246); MSH4 (O15457); MSH5 (O43196); MSH6 (P52701); NBN
(O60934); PARP1 (P09874); PARP2 (Q9UGN5); PARP3 (Q9Y6F1);
RAD17 (O75943); RAD21 (O60216); RAD50 (Q92878); RAD51
(Q06609); RAD51B (O15315); RAD51C (O43502); RAD51D (O75771);
RAD52 (P43351); RAD54B (Q9Y620); RAD54L (Q92698); REV1
(Q9UBZ9); RPA1 (P27694); RPA2 (P15927); RPA3 (P35244); SIRT1
(Q96EB6); TP53BP1 (Q12888); WRN (Q14191); XRCC1 (P18887);
XRCC2 (O43543)
NHEJ Non-homologous end-joining 22
ATM (Q13315); ATP23 (Q9Y6H3); BRCA1 (P38398); ERCC1 (P07992);
ERCC4 (Q92889); LIG4 (P49917); MDC1 (Q14676); MLH1 (P40692);
MRE11 (P49959); NBN (O60934); PARP1 (P09874); PARP2 (Q9UGN5);
PARP3 (Q9Y6F1); PRKDC (P78527); RAD50 (Q92878); SIRT1
(Q96EB6); TP53BP1 (Q12888); WRN (Q14191); XRCC1 (P18887);
XRCC4 (Q13426); XRCC5 (P13010); XRCC6 (P12956)
Other DNA Repair Pathways
POL Polymerases 4 PCNA (P12004); POLB (P06746); POLD3 (Q15054); REV1 (Q9UBZ9)
DRD Direct reversal of damage 3 ALKBH1 (Q13686); ALKBH3 (Q96Q83); MGMT (P16455)
SMNP Sanitization/modulation ofnucleotide pools 3 DUT (P33316); NUDT1 (P36639); RRM2B (Q7LG56)
FA Fanconi anemia 9
BRCA1 (P38398); BRCA2 (P51587); BRIP1 (Q9BX63); FANCA
(O15360); FANCB (Q8NB91); FANCF (Q9NPI8); FANCG (O15287);
RAD51 (Q06609); RAD51C (O43502)
TLM Telomere maintenance 26
ATR (Q13535); BRCA1 (P38398); BRCA2 (P51587); ERCC1 (P07992);
ERCC4 (Q92889); FEN1 (P39748); MRE11 (P49959); NBN (O60934);
PARP1 (P09874); PARP3 (Q9Y6F1); PCNA (P12004); POLD3 (Q15054);
RAD50 (Q92878); RAD51 (Q06609); RAD51C (O43502); RAD51D
(O75771); RFC1 (P35251) RPA1 (P27694); RPA2 (P15927); RPA3
(P35244); SIRT1 (Q96EB6); TP53 (P04637); WRN (Q14191); XRCC1
(P18887); XRCC5 (P13010); XRCC6 (P12956)
TLS Translesion synthesis 3 PCNA (P12004); POLD3 (Q15054); REV1 (Q9UBZ9)
CSM Chromatin structure andmodification 16
CHEK1 (O14757); ERCC6 (Q03468); FEN1 (P39748); H2AFX (P16104);
LIG3 (P49916); PCNA (P12004); RAD17 (O75943); RAD21 (O60216);
RAD51 (Q06609); RAD51C (O43502); RPA1 (P27694); RPA2 (P15927);
RPA3 (P35244); SIRT1 (Q96EB6); TP53 (P04637); XRCC1 (P18887)
MMEJR Microhomology-mediatedend-joining repair 6
FEN1 (P39748); LIG3 (P49916); MRE11 (P49959); NBN (O60934);
PARP1 (P09874); XRCC1 (P18887)
SDA
Genes defective in diseases
associated with sensitivity to
DNA-damaging agents
7 ATM (Q13315); ATXN3 (P54252); BLM (P54132); ERCC6 (Q03468);ERCC8 (Q13216); NBN (O60934); WRN (Q14191)
UBM Ubiquitination andmodification (Rad6 pathways) 6
RAD18 (Q9NS91); SHPRH (Q149N8); UBE2A (P49459); UBE2B
(P63146); UBE2N (P61088); UBE2V2 (Q15819)
OTHER Other DNA damage-related 4 CRY1 (Q16526); SUMO1 (P63165); TOP3A (Q13472); TOP3B (O95985)
1 These numbers add up to over 117 (the total number of genes studied) because some of the genes are involved in
more than one pathway.
2.7. Analysis of Clinical Data Obtained from Online Databases
Expression of selected DNA repair genes in lung cancers was determined through analysis in the
cBioPortal database (www.cbioportal.org) [27]. Two clinical datasets of different types of lung cancer,
lung adenocarcinoma (517 samples), and lung squamous cell carcinoma (501 samples), were obtained
from The Cancer Genome Atlas (TCGA) database and analyzed. The mRNA expression z-score
threshold was set at ± 1.5; only genes with expression fold-change greater than 1.5 between the tumor
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and normal samples were considered significant. The z-score indicates the relative expression of an
individual gene in the tumor sample to the gene’s expression distribution in a reference population
(normal samples), and it is calculated as ((expression in tumor sample – mean expression in reference
sample) ÷ standard deviation of expression in reference sample).
2.8. Statistical Analysis
Statistical analysis was performed using the GraphPad Prism® 6 software (v6.02, GraphPad
Software Inc.). All values in the bar charts and line charts are expressed as mean ± standard deviation
(SD). All experiments were performed at least three times, and they showed similar trends in their results.
Results from one representative experiment were shown unless mentioned otherwise. Two-tailed
Student’s t-test was used to determine significant differences between the means of analyzed data
unless mentioned otherwise. p ≤ 0.05 was considered statistically significant.
3. Results
3.1. Establishment of a Post-Chronic Cd-Exposed BEAS-2B Cell Line (the “CR0” Cells)
Previously, we established a transformed BEAS-2B cell line which was stepwise-adapted to
environmentally-relevant concentrations of CdCl2 (1–20 µM) [19]. Cells from this cell line exhibited
transformed cell phenotypes as evidenced by their ability to anchorage-independent growth on soft
agar and enhanced cell migration. We also found that Cd could induce epigenotoxicity in the BEAS-2B
cells as the levels of several important histone post-translational modification (PTM) marks, including
those involved in DNA repair, were significantly altered upon chronic Cd exposure. These results
indicated that Cd could exert its toxic effects to the cellular epigenetic circuit in which the Cd-induced
toxicity might be heritable. Here, we established a post-chronic Cd-exposed cell line by culturing the
Cd-transformed BEAS-2B cells in Cd-free condition for at least 12 months (Figure 1A). The post-chronic
Cd-exposed BEAS-2B cells are termed as “CR0” while the passage-matched control cells are termed as
“PM”, and they are used in the current study as unique cell models to study the effects of post-chronic
Cd exposure on DNA repair system in human lung cells.
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Figure 1. Establishment of a post-chronic Cd-exposed human lung cell line and evaluation of
its Cd-resistance and DNA damage and repair capacity. (A) Schematic of the establishment of
chronic and post-chronic Cd-exposed BEAS-2B cell line used in the previous [19] and current
study; the post-chronic Cd-exposed BEAS-2B cells are termed as “CR0” while the passage-matched
control cells are termed as “PM”. (B,C) Cell proliferation rate of CR0 and PM cells grown
in standard LHC-9 medium or culture medium containing 20 µM CdCl2 was measured by
3-(4,5-di ethylthiazol-2-yl)-5-(3-carboxy ethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay.
Results are representative of at least three independent experiments, and error bars represent mean ±
SD of at least three technical replicates. (D) Colony formation assay of PM and CR0 cells treated with 20
µM of CdCl and grown for 7–10 days.
3.2. Cd-Resistant Cells Retain Cd Tolerance Feature for an Extended Period of Time
We compared the growth rates of both CR0 and PM cells and discovered that CR0 cells had
decreased cell proliferation when cultured in normal Cd-free growth medium (Figure 1B). However,
when cultured in medium supplied with 20 µM of CdCl2, the CR0 cells showed greater cell proliferation
than the PM control cells, although an overall reduction in growth rate was observed in both CR0 and
PM cells (Figure 1C). In addition, colony formation assay revealed that CR0 cells were able to form
significantly more colonies than the PM control cells (Figure 1D; Figure S1A). These results indicate
that CR0 cells are still able to tolerate Cd to some extent. However, the tolerance level of CR0 cells is
lower as compared to our previously established transformed BEAS-2B cells that were still maintained
in 20 µM CdCl2 at the time of experiment, suggesting the potential of Cd-resistant cell lines to lose
their Cd resistance trait over time when grown in a Cd-free condition for an extended period of time
(Figure S1B).
3.3. Exposure to Cd Resulted in Cells Having Lasting DNA Damage and Reduced DNA Repair Capacity
It is well-documented that acute/chronic Cd exposure can disrupt cellular DNA repair system,
but the effects of post-chronic Cd exposure remain elusive. Here, we checked the native/intrinsic DNA
damage in CR0 cells using the comet assay and revealed that when compared to PM cells, the CR0
cells possess greater DNA damage as shown by higher % tail DNA and tail extent moment values
(Figure 2A,B). We then assessed the expression of histone γH2AFX (a well-known DNA damage
indicator) in the CR0 cells and found that CR0 cells have higher H2AFX and γH2AFX expressions
(Figure 2C; for full blot see Figure S2). This result again reinforced that CR0 cells have higher intrinsic
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DNA damage as phosphorylation of histone H2AFX (γH2AFX) is known to be highly correlated with
DNA damage and repair events in the cells [28].
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images of comet assay in PM and CR0 cells stained with 5 µg/mL of propidiu i dide after gel
electrophoresis. (C) Expres on of histone H2AFX and phosphorylated H2AFX (γH2AFX) were
determined by Western blot (see Figure S2 for full blot). (D,E) Cell viability of PM nd CR0 cells
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moment of PM and CR0 cells exposed to 0, 2.5, and 10 µM of H2O2 for 2 h without or with a 24 h
recovery period was analyzed by comet assay. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001.
To assess the DNA repair capacity of the CR0 cells, we exposed the cells to H2O2, a DNA damaging
agent that induces ssDNA breaks, and measured their cell viability and DNA damage upon direct
or post (24 h recovery time) H2O2 exposure. The cell survivability test indicated that CR0 cells are
generally more sensitive to H2O2 than the PM cells (Figure 2D,E). In terms of DNA damage, both PM
and CR0 cells show very high DNA damages when exposed to H2O2 for 2 h (Figure 2F). This was an
expected result since H2O2 is known for inducing severe DNA damage and is often used as a positive
control in comet assays [22]. Although no significant differences were observed due to large error bars,
it appeared that CR0 cells might have greater DNA damages than the PM cells upon H2O2 exposure,
which was more obvious after a 24 h recovery period (Figure 2F). Taken together, these results not only
show that the CR0 cells have a lower DNA repair capacity, but also indicates that they were likely to be
more susceptible to DNA damage-inducing agents.
3.4. Aberrant Expression of DNA Repair Gene Profile Is Associated with Post-Chronic Cd Exposure
DNA repai is a complicated process that involves a network of multiple pathways and hundreds
of genes. Here, we screened the expression of 117 DNA repair-related genes involved in 16 different
DNA repair pathways in the PM and CR0 cells (see Table 1). Here, we developed a “scoring system” in
order to more accurately assess the DNA repair gene expression profile data. Unlike the conventional
method where only one reference/housekeeping gene is used, in our scoring system, multiple reference
genes were utilized to normalize the expression of the analyzed genes. Specifically, each DNA repair
gene was individually normalized to six different reference genes: ACTB, B2M, GAPDH, HPRT1,
PRLP0, and “5HKGs”, and a significance-score (s-score = 1) was given when a gene showed significant
results (p ≤ 0.05 and fold-change ≥1.5) upon normalization to a reference gene (Figure S3A–F; Table S2).
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Out of the 117 DNA repair genes, 52 genes were shown to be significantly up- or down-regulated
in the PM vs. CR0 cells when normalized to either one of the six reference genes (with s-score ≥ 1;
Figure S4A). However, to diminish false-positive results, we only considered genes with s-score ≥ 4
to be truly significant. Based on this requirement, only 12 genes qualified, as shown in Figure 3A,
in which 10 genes were up-regulated (DUT, GADD45A, GTF2H2, H2AFX, LIG3, MBD4, PCNA, PMS2,
REV1, and SUMO1) and only two were down-regulated (ABL1 and NEIL1) (Figure S4B).
Unlike previous studies where most DNA repair genes were reported to be suppressed upon
acute or chronic Cd exposure [4,6–8,13,29,30], up-regulation of 10 out of 12 DNA repair genes in this
study suggests that acute/chronic and post-chronic Cd-exposed cells have different transcriptomic
landscapes of DNA repair. Most importantly, the DNA repair transcriptome of the CR0 cells also
suggests that chronic Cd exposure has long-term effects on the expression of DNA repair-related genes
in human lung cells.
The 12 differentially expressed DNA repair genes identified in our study are recognized to be
involved in a diverse range of DNA repair pathways (Figure S4C). However, it appears that Cd may
selectively have a greater influence on certain DNA repair pathways. Taking the five major repair
pathways for example, five (GADD45A, LIG3, MBD4, PCNA, and NEIL1), four (GADD45A, GTF2H2,
LIG3, and PCNA), and three (PCNA, PMS2, and ABL1) genes were involved in the major ssDNA
damage repair: BER, NER, and MMR, respectively. However, as for the dsDNA damage repair, only
four (GADD45A, H2AFX, LIG3, and REV1) genes were involved in the HRR and none for the NHEJ.
These findings are remarkably similar with available literature where the evidence for Cd interference
in BER, NER, and MMR is overwhelming, but not much on the repair of dsDNA breaks involving
HRR and NHEJ [4–6].
Furthermore, some of the DNA repair genes investigated in this study were selected for
immunoblotting analysis (Figure S5). Results indicated that the protein expressions of most of
the selected genes, including H2AFX, LIG3, PMS2, and NEIL1, were largely in agreement with their
gene expression profiles. In summary, this is the first report to show that the expression of a panel of
DNA repair genes was altered in response to post-chronic Cd exposure.
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Figure 3. DNA repair gene expression profile associated with Cd exposure. (A) Volcano plot of
117 DNA repair gene expression profiles of CR0 over PM cells when normalized to 5-housekeeping
genes (5HKGs), modified from Figure S3F. Only expression of genes with an s-score (s) ≥ 4 were
considered as significantly altered and highlighted in green (down-regulated) or red (up-regulated).
Specifically, to gain an s-score (s = 1), a gene has to be p ≤ 0.05 and fold-change ≥1.5 upon normalization
to a selected reference gene. Six references genes (ACTB, B2M, GAPDH, HPRT1, PRLP0, and 5HKGs)
were used. Vertical lines on the x-axis represent 1.5 or –1.5 fold-change; dash line on the y-axis represents
p ≤ 0.05. (B,C) Expression of the 12 differentially expressed DNA repair genes in PM and CR0 cells
treated with 20 µM of CdCl2 for 72 h. Only expressions of genes with s ≥ 4 (highlighted in red asterisk)
were considered significantly altered.
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3.5. Short-Term Cd Exposure Reveals Different DNA Repair Transcriptomic Landscapes in Normal and
Cd-Exposed Cells
We then evaluated the effects of short-term Cd exposure on the expression of the 12 differentially
expressed DNA repair genes identified in the current study by treating both PM and CR0 cells with
20 µM of CdCl2 for 72 h. Interestingly, results indicated that most of the genes were down-regulated
in the PM cells (Figure 3B) but up-regulated in the CR0 cells (Figure 3C). Specifically, three genes
(LIG3, PCNA, and REV1) were significantly down-regulated in the PM cells whereas four genes (ABL1,
H2AFX, LIG3, and PMS2) were significantly up-regulated in the CR0 cells. For the PM cells, only
two genes, GADD45A and H2AFX, appeared to be up-regulated but the expression changes were not
considered significant based on our criteria for analyzing the gene expression data (the s-score is not
≥4; Table S3). Overall, these results again indicate that the normal (PM) and Cd-transformed (CR0)
lung cells have different transcriptomic landscapes of DNA repair and suggest that both cell lines
would likely react differently towards environmental stimuli such as Cd.
3.6. Clinical Database Analysis of Lung Cancer Samples with Different Smoking Histories
A reduced DNA repair ability or an impaired DNA repair system can cause a cell to accumulate
DNA damages and mutations, which may eventually become malignant. Thus, cells exposed to Cd
have the potential to become cancerous. Here, we utilized online clinical datasets (TCGA, provisional)
to analyze the expression of the 12 differentially expressed DNA repair genes in lung cancer patients
with lung adenocarcinoma (517 samples) or lung squamous cell carcinoma (501 samples). We found that
the expressions of these 12 genes were significantly altered (mRNA expression z-score threshold ± 1.5)
in 6%–16% of lung adenocarcinoma patients (31–83 out of 517 patients) (Figure S6A) and in 2.8%–36%
of lung squamous cell carcinoma patients (14–180 out of 501 patients) (Figure S6B), depending on the
gene analyzed. Interestingly, the majority of these DNA repair genes, with the exception of ABL1, tend
to be up-regulated in their expressions (ABL1 is also down-regulated in the CR0 cells). These results
are highly similar to the DNA repair gene expression profile of the CR0 cells, where only NEIL1 was
the one gene that did not match (down-regulated in CR0 cells but up-regulated in lung cancer patients
analyzed). Thus, these findings indicate that the expression profile of the DNA repair genes identified
in our study may possibly be used to define abnormal lung cells and suggest that the Cd-transformed
CR0 cells may be cancerous, also as supported by our previous study [19].
Since cigarette smoking is one of the primary sources of Cd exposure in humans [17,31], we utilized
the same clinical datasets and analyzed the expression of the 12 genes based on different patient
smoking history categories: lifelong non-smoker, current smoker, current reformed smoker for≤15 years,
and current reformed smoker for >15 years (Figure 4). It was shown that the lung adenocarcinoma
dataset (Figure 4A) was more variable in gene expression than the lung squamous cell carcinoma
dataset (Figure 4B). The above data are also summarized in Table S4. For lung adenocarcinoma,
four genes (H2AFX, LIG3, NEIL1, and PCNA) in the “non-smoker vs. smoker” and “non-smoker vs.
ex-smoker (≤15 years)” categories show the same gene expression patterns as the PM versus the CR0
cells: up-regulated H2AFX, LIG3, and PCNA and down-regulated NEIL1. However, the expressions
of these four genes are all becoming opposite in “smoker vs. ex-smoker (≤15 years)”, “smoker vs.
ex-smoker (>15 years)”, and “ex-smoker (≤15 years) vs. ex-smoker (>15 years)”. In addition, LIG3 is
the only gene that shows the same expression trend in “non-smoker vs. smoker” and “non-smoker vs.
ex-smoker (≤15 years)” in both datasets. Overall, these results showed that smoking might play a role
in the expression of some of these DNA repair genes in lung cancer patients, particularly in patients
with lung adenocarcinoma.
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Figure 4. Box and whisker plots of the expression of 12 differentially expressed DNA repair genes
associated with post-chronic Cd exposure. Two datasets, (A) lung adenocarcinoma samples and (B) lung
squamous cell carcinoma samples with different smoking history, were analyzed. Data were derived
from The Cancer Genome Atlas (TCGA, provisional) and sorted using cBioPortal database. The box and
whiskers plots are plotted in the style of 10–95 percentile. Smoking status: A = lifelong non-smoker
(76 samples for lung adenocarcinoma; 18 samples for lung squamous cell carcinoma samples); B = current
smoker (119 samples; 133 samples); C = current reformed smoker for ≤15 years (135 samples; 250 samples);
D = current reformed smoker for >15 years (169 samples; 83 samples). Two-tailed Student’s t-test was used
to determine significant differences between the means of the groups. p ≤ 0.05 was considered statistically
significant. * p ≤ 0.05; ** p ≤ 0.01; *** p ≤ 0.001; **** p ≤ 0.0001.
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3.7. Post-Chronic Cd Exposure Resulted in Cells Having Reduced DNA Repair Capacity and More Susceptible
to Chemotherapy
There is currently no information on how post chronic Cd-transformed cells would react to
anticancer treatment. Taking advantage of our established post-chronic Cd-exposed CR0 cells,
we investigated the sensitivity of this cell line against three chemotherapeutic drugs: cisplatin,
gemcitabine, and vinorelbine tartrate. Here, PM and CR0 cells were correspondingly treated with
various concentrations of the above chemotherapeutic drugs for 48 h and their viability was measured
directly or after a 24 h recovery period. Results show that CR0 cells were generally more sensitive to
all the drugs tested than the PM control cells (Figure 5A–F).
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Figure 5. Cell viability of PM and CR0 cells exposed to selected chemotherapeutic drugs. Three drugs
were tested: (A,B) cisplatin, (C,D) gemcitabine, and (E,F) vinorelbine tartrate. Cells were treated with
various concentrations of the above chemotherapeutic drugs for 48 h and their viability was measured
by MTS assay (A,C,E) directly or (B,D,F) after a 24 h recovery period. Results are representative of
at least three independent experiments with a similar survival trend. The percentage of viability
was plott d s 100% for untreated CR0 or PM controls. Error bars represent mean ± SD of at least
four tech ical replicate . Two-way ANOVA was used to determine significan differences between
CR0 and PM by comparing the means at each concentration point, and p ≤ 0.05 was considered
statistically significant.
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We also assessed the DNA damage and repair capacity of the PM and CR0 cells when exposed
to cisplatin, gemcitabine, and vinorelbine tartrate via comet assays. Under normal circumstances,
increased % tail DNA and tail extent moment indicate greater DNA damages and/or reduced DNA
repair ability. However, both PM and CR0 cells showed slightly reduced % tail DNA and tail extent
moment when exposed to cisplatin but showed increased % tail DNA and tail extent moment after
a 24 h recovery period due to the cisplatin’s mechanism of action (Figure 6A,B). Cisplatin binds to DNA
to form intra- and inter-strand crosslinks and thereby, inhibits DNA replication [32]. The crosslinks
between cisplatin and DNA cannot readily be unwound by the alkaline comet assay, resulting in
decreased DNA electrophoretic mobility [33]. Hence, the decrease in tail extent moment is indicative
of crosslink formation, whereas the increase in tail extent moment after a recovery period indicates
crosslink repair (Figure 6B).
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Figure 6. DNA damage and repair capacity of PM and CR0 cells exposed to selected chemotherapeutic
drugs. Three drugs were tested: (A,B) cisplatin, (C,D) gemcitabine, and (E,F) vinorelbine tartrate.
Cells were treated with two selected concentrations of the above chemotherapeutic drugs for 48 h and
their DNA damages were measured by comet assay directly or after a 24 h recovery period. Two DNA
damage parameters are shown: (A,C,E) % tail DNA and (B,D,F) tail extent moment. Results shown
are ratio over untreated PM-control. Error bars represent mean ± SD of three separate experiments.
Dash line on the y-axis represents ratio value of PM-control at one.
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When exposed to gemcitabine and vinorelbine tartrate, CR0 cells generally showed greater DNA
damage and reduced repair capacity (Figure 6C–F). Results indicated that the % tail DNA and tail
extent moment of the CR0 cells were always greater than the PM cells when treated with the same
concentration of gemcitabine or vinorelbine tartrate. Also, CR0 cells showed significant increases
in tail extent moment when treated with increased concentrations of gemcitabine at 48 h but the
PM cells maintained relatively the same (Figure 6D). These results again show that CR0 cells have
reduced DNA repair capacity and they are much more vulnerable to the chemotherapeutic drugs
tested. Overall, the above findings suggest that Cd-induced lung cancer could be more effectively
treated with chemotherapy.
4. Discussion
To the best of our knowledge, this is the first study to investigate the long-term effects of
post-chronic Cd exposure in human lung cells. This study is also the first to systematically examine the
expression of DNA repair genes upon post-chronic Cd exposure on a large-scale. Cd is a cumulative
toxin of increasing environmental and occupational concern because of its long biological half-life [34].
Cd occurs naturally in the living environment and has been widely used in the field of industry
since the beginning of the 1940s [35]. Although the exact molecular mechanisms are not yet fully
understood, the potential of acute and chronic Cd exposure to cause cytotoxicity and carcinogenicity
has been documented in many experimental and epidemiological studies [10–15]. However, knowledge
regarding post-chronic Cd exposure is lacking. One of the main challenges in the post Cd (or other
carcinogens) exposure-related research is the lack of such cell models.
In regard to human subjects, it is extremely difficult to define samples that are only exposed to
Cd since the exposure to environmental pollutants is often multifaceted and multifactorial, and it
is likely to result in complex toxic interactions in the body [36]. Therefore, in order to understand
the mechanisms underlying cytotoxic or carcinogenic effects of Cd in humans, establishments of
long-term and immortalized human lung epithelial cell cultures or lung tissue from animal models
are essential [3]. In the current study, we established a post Cd-exposed human bronchial epithelial
BEAS-2B cell line (the CR0 cells) to study the effects of post-chronic Cd exposure on DNA damage
and repair.
The CR0 cells were established from the BEAS-2B cells because previous studies have shown that
different organs exhibit a different Cd absorption rate, and lung tissue is one of the main targets of Cd
toxicity [2,37,38]. It was estimated that more than 50% of Cd could be absorbed by the lungs whereas
only less than 10% of ingested Cd was absorbed in the gastrointestinal system [37]. This may help
explain why the most obvious correlation between Cd and human diseases is found in the lungs [39].
Additionally, Cd is a well-known carcinogen where it particularly shows a strong correlation with lung
cancer [40]. In fact, Cd has been classified as a top human carcinogen by international organizations
such as the World Health Organization’s International Agency for Research on Cancer [41].
Previously, the expression of many important DNA repair genes (e.g., CRY1, ERCC1, LIG4,
MLH1, MSH2, MSH6, MSH7, OGG1, PCNA, RAD21, RAD50, XRCC1, and XRCC4) in human, animal,
or plant cells were found to be suppressed by Cd [6,8,13,29,30]. In Zhou et al., the overexpression of
DNA methyltransferase genes (DNMT1 and DNMT3a) resulted in the silencing of DNA repair genes
(MSH2, ERCC1, XRCC1, and OGG1) in CdCl2-transformed human bronchial epithelial 16HBE cells
and tumorigenic cells isolated from a xenograft nude mouse model [7]. However, the expression of
most of the abovementioned genes from previous studies was not differentially expressed in the CR0
cells in the current study. Here, the differently expressed DNA repair genes identified in the CR0
cells were mostly up-regulated (ten genes up and only two down), and this may be due to the lasting
DNA damage found in the cells because the cells require more DNA repair proteins to cope with
the damages. These findings indicate that acute/chronic and post-chronic Cd exposures resulted in
different transcriptomic landscapes of DNA repair.
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Expression of several DNA repair genes in CR0 cells and control PM cells also appeared to
be different upon short-term Cd exposure: down-regulated in the PM cells but up-regulated in the
CR0 cells. These results again indicated that both cell lines had different transcriptomic landscapes
and would likely react differently towards environmental stimuli. The up-regulation of DNA repair
gene expression in the CR0 cells is certainly an interesting and distinctive feature of the post-chronic
Cd-exposed cell line and may be used as biomarkers for identifying post-chronic Cd exposure.
In this study, we developed a “scoring system” involving the use of multiple reference genes for
RT-qPCR. The main purpose of the reference gene (or so-called the housekeeping gene), is to normalize
the amount of cDNA added for the RT-qPCR. A reference gene is expected to be universally expressed
in all cells of an organism, and the gene expression is unaffected by the cell types, developmental stage,
cell-cycle state, and most importantly, experimental treatments [25]. Although it is recommended to
validate the reference gene for each experiment (e.g., by performing serum starvation and induction
experiments), there is no guarantee that the validated reference gene is not affected by the experimental
factors [42]. Also, many of the common housekeeping genes (e.g., ACTB and GAPDH) could potentially
have abnormal expressions in cancerous cells. The problems regarding reference gene selection for
RT-qPCR are addressed in Eisenberg and Levanon [43]. Here, our novel scoring system provides a less
biased method to analyze gene expression data based on the 2-∆∆CT method, especially for a cohort of
genes that is anticipated to have low expression fold-change value.
Tumorigenesis is promoted by genome instability with increased DNA damage and reduced
DNA repair capacity [40]. Thus, based on the confirmed characteristics of the CR0 cells (transformed
phenotypes, greater intrinsic DNA damage, aberrant DNA repair gene expression profile, and reduced
DNA repair capacity), it is indicated that post-chronic Cd-exposed cells are highly prone to malignant
transformation. The BEAS-2B cell line was regularly used to investigate the carcinogenic effects of
cigarette smoke on human lung cells in many previous studies [44,45]. However, the smoking history of
the individual whose primary bronchial cells were obtained to generate the cell line was not documented,
and this has not been addressed in any of the previous studies. As a matter of fact, information of
smoking status is usually lacking in many established cell lines, even in some of the lung cancer cell
lines, which could be a disadvantage for research regarding cigarette smoke-induced carcinogenesis.
Nevertheless, here we used online clinical datasets to evaluate the relationships between DNA repair
genes, lung cancer, and cigarette smoking, and showed that some of the DNA repair genes might
play a role in lung cancer and smoking. However, this database analysis has several limitations. First,
the development of cancer is complicated and cannot be attributed to only a single (or a few) gene
expression. Second, although smoking is one of the primary sources of Cd exposure in human [17,31],
Cd is not the only carcinogens present in cigarettes. In fact, smokers are exposed to a toxic mixture of
over 7000 chemicals, in which many are recognized as carcinogens, from cigarette smoking [46].
Studies have shown that Cd exposure may cause tumor cells to exhibit resistance to oxidants,
radiation, and to the action of many chemotherapeutic agents due to up-regulation of gene and
protein expression of several resistance factors, such as glutathione and metallothionein [47]. However,
results obtained in our study showed that the CR0 cells were more sensitive to chemotherapeutic
(cisplatin, gemcitabine, and vinorelbine tartrate) and DNA damaging (H2O2) agents than the PM
control cells. These results suggest that Cd-exposed and post Cd-exposed cells are likely to respond
differently toward chemotherapeutic drugs, probably due to the expression changes in the resistance
factors, although further work is required to confirm this. Nevertheless, more DNA damage-related
chemotherapeutic drugs and radiotherapy should be tested on the CR0 cells in order to see if the reduced
DNA damage repair capacity of post Cd-exposed cells can result in a better anticancer treatment
outcome. In addition, there are several other experiments that can be performed in the future to enhance
our knowledge regarding the molecular mechanism of Cd-induced carcinogenicity, including studying
the epigenotoxicity effects of Cd using the CR0 cell model established here. The three main epigenetic
components, namely the DNA methylation, histone PTMs, and ncRNA expression, could be assessed
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using high-throughput sequencing or microarray techniques [48]. Recent studies have revealed that
Cd exposure and smoking affect the global DNA methylation profiles in human [18,49–51].
Although we have shown that the CR0 cells have different transcriptomic landscapes of DNA
repair and the abovementioned properties than acute/chronic Cd-exposed cells, it is less clear when the
CR0 cells acquired their properties during the post-exposure period. In order to assess the dynamic
changes upon post-chronic Cd exposure, future experiments could also be performed in BEAS-2B cells
collected at multiple time points (e.g., 1st month, 2nd month, 3rd month and up to 12th month and
more) after chronic-Cd exposure, along with their passage-matched controls.
Overall, this study unveiled a new perspective for the environmental health hazard of Cd
and will encourage further research on post-Cd (and other carcinogens) exposure. Research on
post-chronic Cd exposure is not only relevant to people like ex-smokers and retired workers in high-risk
occupations, but also to people from the general population who live in Cd-polluted environments.
In addition, our findings regarding CR0 cells’ decreased DNA repair capacity and increased sensitivity
to chemotherapeutic and DNA damaging agents may have important health and clinical implications
(especially for lung cancer patients). These findings suggest that Cd-induced lung cancer can be more
effectively treated with chemotherapy, but this also poses a serious health concern: “normal” cells may
also be more vulnerable to these chemotherapeutic drugs upon chronic or post-chronic Cd exposure.
Therefore, in addition to promoting carcinogenesis, Cd exposure also has the potential long-term
effects of making patients that have to undergo chemotherapy more susceptible to the toxicity of the
chemotherapeutic drugs, as demonstrated in Figure 7.
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5. Conclusions
In conclusion, this study encourages further research on the previously uncharted territory of
post-Cd exposure by revealing the long-term effects of post-chronic Cd exposure on DNA repair
systems in a novel post Cd-exposed cell model. We demonstrated for the first time that the human
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lung cell exhibits lasting high levels of DNA damage associated with Cd exposure. We showed that the
post-chronic Cd-exposed human lung cells had retained Cd-resistance property, aberrant expression of
DNA repair genes, reduced DNA repair capacity, and were more susceptible to chemotherapeutic and
DNA damaging agents.
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at 495 nm). Figure S2: Western blot of histones extracted from CR0 and PM cells probed with H2AFX (1:1000,
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